Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 4 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Hemostatic Disorders 1

Interventions

Gemcitabine 16 Fluorouracil 6 Irinotecan 4 Cisplatin 4 Capecitabine 4 Oxaliplatin 3 Albumin-Bound Paclitaxel 3 130-nm albumin-bound paclitaxel 3 nimotuzumab 2 Taxes 2 Phytotherapy 2 Leucovorin 2 Drug Therapy 2 surufatinib 1 rubitecan 1 racemetyrosine 1 pertuzumab 1 pembrolizumab 1 methylnaltrexone 1 folfirinox 1 cyclopropapyrroloindole 1 camrelizumab 1 Trastuzumab 1 Tranexamic Acid 1 Standard of Care 1 Sirolimus 1 Radiotherapy 1 Positron Emission Tomography Computed Tomography 1 Phenytoin 1 Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Pancreatic Neoplasms × Enoxaparin × Clear all

NCT00785421 2015-01-08

PROSPECT

CONKO-Studiengruppe

Phase 2/3 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡